D-0004-2022 Class II Terminated
FDA drug recall D-0004-2022 was initiated by Akorn, Inc. on Oct 4, 2021 and is designated Class II. Reason for recall: Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point. The recall status is terminated (terminated Aug 17, 2022). Affected quantity: 10,210 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 13, 2021
- Initiation Date
- Oct 4, 2021
- Termination Date
- Aug 17, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,210 bottles
Product description
Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11
Reason for recall
Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot 0B61A, Exp 01/31/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0004-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026